Jim Cramer Shares His Thoughts On Chegg, Bristol-Myers Squibb And More
On CNBC’s "Mad Money Lightning Round," Jim Cramer said with Matterport, Inc. (NASDAQ: MTTR) already moving too much, "I’m going to have to take a big pass."
Earnings Scheduled For November 4, 2021
Companies Reporting Before The Bell
• DISH Network (NASDAQ:DISH) is likely to report quarterly earnings at $0.91 per share on revenue of $4.45 billion.
Bionano Genomics Highlights Updates To Its Solve, Access Data Solutions
Bionano Genomics, Inc. (BNGO), developer of the Saphyr® system that uses optical genome mapping (OGM) for the detection and analysis of structural variants (SVs), today announced the release of Bionano
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected.
Jim Cramer Prefers This Stock Over Mogo, Considers Endeavor Group As Inexpensive
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he prefers Intuit Inc. (NASDAQ: INTU) over Mogo Inc.
What’s Up With Bionano Genomics Today?
Bionano Genomics Inc. (NASDAQ: BNGO) shares are trading higher Tuesday after the company announced it agreed to buy BioDiscovery Inc, a provider of software for analysis, integration and reporting of genomic data.
Bionano Genomics Announces The Publication Of Clinical Research Study To Date Evaluating Optical Genome Mapping For Facioscapulohumeral Muscular Dystrophy
Bionano Genomics, Inc. (BNGO) today announced the publication of the largest clinical research study to date evaluating optical genome mapping (OGM) for facioscapulohumeral muscular dystrophy (FSHD), which concluded that
Bionano Genomics Announces Study Finds The Combination Of Optical Genome Mapping And Short-Read Sequencing Provides A Comprehensive Genome Analysis For Lung Cancer Samples And Enables The Discovery Of New Biomarkers
Bionano Genomics, Inc. (NASDAQ:BNGO) today announced a study finding the combination of optical genome mapping (OGM) and short-read next-generation sequencing (NGS) provides a comprehensive genome analysis for lung
If You Invested $1,000 In BioNano Stock One Year Ago, Here’s How Much You’d Have Now
Investors who have owned stocks in the last year have generally experienced some big gains. In fact, the SPDR S&P 500 (NYSE: SPY) total return over the last 12 months is 37.1%. But there is no question some big-name stocks performed better than others along the way.